EpicentRx Inc

United States
San Diego, California, United States, 92037

Company profile

EpicentRx Inc company profile

With a prolific platform of small molecule therapies, innate immune checkpoint inhibitors, cell based therapies, vaccines and oncolytic viruses, the central focus of EpicentRx Inc., a privately owned physician-led phase 3 clinical-stage immuno-oncology company located in San Diego, California, is on anticancer immunization and chemo/radioprotection of normal tissues. As a company of actively practicing oncologists/internists they at EpicentRx take cancer very very personally (in a literal and figurative sense) with the plight of the patient serving first and foremost as the motivation to customize or personalize their platform of immunotherapies both to individuals that are otherwise out of options and to groups of individuals with common and in many cases currently undruggable mutations.

Business identity

Contact email
[email protected]
Phone number
(858) 947-6635
Operating status
Active
Company type
For Profit
Employee range
11-50 employees
Revenue range
$0-$1M
Founded
2002-01-01

Headquarters

Postal code
92037
Country code
US
Continent
North America

Capital profile

Funding and company signals

Funding stage
Late Stage Venture
Funding rounds
2
Total equity funding
$35M
Last funding
Grant / $500,000 / 2022-07-12
Last equity funding
Series D / $35M
Investors
1
Lead investors
1
Founders
1
Articles
28

Founders and investors

Founders

Jan Scicinski

Lead investors

Michael J. Fox Foundation

Investors

Michael J. Fox Foundation